Lung Cancer | Melissa Johnson, MD

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 8: Selection and sequencing of treatment for patients with metastatic NSCLC with alterations in ALK, ROS1, RET and NTRK — Dr Johnson. CME information and select publications